Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial

Neurosurgery

Volumn 72, Issue 5, 2013, Pages 777-795

  Derdeyn, Colin P ^a   Fiorella, David ^b   Lynn, Michael J ^c   Rumboldt, Zoran ^d   Cloft, Harry J ^e   Gibson, Daniel ^a   Turan, Tanya N ^e   Lane, Bethany F ^c   Janis, L Scott ^f   Chimowitz, Marc I ^e  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

^d MAYO CLINIC   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Angioplasty and stenting; Hemorrhage; Stroke

Indexed keywords

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BASILAR ARTERY; BRAIN ATHEROSCLEROSIS; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRACRANIAL ATHEROSCLEROTIC DISEASE; INTRAPARENCHYMAL HEMORRHAGE; MALE; MULTICENTER STUDY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STENT; SUBARACHNOID HEMORRHAGE;

AGED; ANGIOPLASTY; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; FEMALE; HUMANS; INCIDENCE; INTRACRANIAL ARTERIOSCLEROSIS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; STENTS; STROKE; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 84876703969     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e318286fdc8     Document Type: Article

References (18)

1. Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365(11):993-1003.
2. Fiorella D, Derdeyn CP, Lynn MJ, et al. Detailed analysis of periprocedural strokes in patients undergoing intracranial Stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS). Stroke. 2012;43(10):2682-2688.
3. Derdeyn CP, Fiorella D, Lynn MJ, et al. Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial [published online ahead of print]. J NeuroInterventional Surg. 2012.
4. Chimowitz MI, Lynn MJ, Turan TN, et al. Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis. 2011;20(4):357-368.
5. Turan TN, Lynn MJ, Nizam A, et al. Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial. Circ Cardiovasc Qual Outcomes. 2012;5(5):e51-e60.
6. Nahab F, Lynn MJ, Kasner SE, et al. Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology. 2009;72(23): 2014-2019.
7. Jiang WJ, Du B, Hon SF, et al. Do patients with basilar or vertebral artery stenosis have a higher stroke incidence poststenting? J Neurointerv Surg. 2010;2(1):50-54.
8. Gröschel K, Schnaudigel S, Pilgram SM, Wasser K, Kastrup A. A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke. 2009;40 (5):e340-e347.
9. Jiang WJ, Srivastava T, Gao F, Du B, Dong KH, Xu XT. Perforator stroke after elective stenting of symptomatic intracranial stenosis. Neurology. 2006;66(12): 1868-1872.
10. Jiang WJ, Du B, Hon SF, et al. Do patients with basilar or vertebral artery stenosis have a higher stroke incidence poststenting? J Neurointerv Surg. 2010;2(1):50-54.
11. Levy EI, Hanel RA, Boulos AS, et al. Comparison of periprocedure complications resulting from direct stent placement compared with those due to conventional and staged stent placement in the basilar artery. J Neurosurg. 2003;99 (4):653-660.
12. Vergouwen MD, Silver FL, Mandell DM, Mikulis DJ, Krings T, Swartz RH. Fibrous cap enhancement in symptomatic atherosclerotic basilar artery stenosis. Arch Neurol. 2011;68(5):676.
13. Shi M, Wang S, Zhou H, Cheng Y, Feng J, Wu J. Wingspan stenting of symptomatic middle cerebral artery stenosis and perioperative evaluation using high-resolution 3 Tesla MRI. J Clin Neurosci. 2012;19(6):912-914.
14. Fiorella D, Levy EI, Turk AS, et al. US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke. 2007;38(3):881-887.
15. Zaidat OO, Klucznik R, Alexander MJ, et al. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology. 2008;70(17):1518-1524.
16. van Mook WN, Rennenberg RJ, Schurink GW, et al. Cerebral hyperperfusion syndrome. Lancet Neurol. 2005;4(12):877-888.
17. Ogasawara K, Sakai N, Kuroiwa T, et al. Intracranial hemorrhage associated with cerebral hyperperfusion syndrome following carotid endarterectomy and carotid artery stenting: retrospective review of 4494 patients. J Neurosurg. 2007;107(6): 1130-1136.
18. Derdeyn CP. Diffusion-weighted imaging as a surrogate marker for stroke as a complication of cerebrovascular procedures and devices. AJNR Am J Neuroradiol. 2001;22(7):1234-1235.